NCT02400164
A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites No drug interventions treatment Not Available completed NCT05867602
High Dose Albumin in Refractory Ascites treatment 2 recruiting NCT04232384
Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosis No drug interventions diagnostic Not Available terminated NCT00501384
Satavaptan Dose-Ranging Study in the Prevention of Ascites treatment 2 completed NCT01403987
Improving Performance of Paracentesis in Medical Residency Training No drug interventions Not Available Not Available completed NCT02417753
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites treatment 2 terminated NCT02821377
Metabolic Effects of Furosemide +HSS in Refractory Ascites treatment 2 completed NCT04767945
Cirrhosis Registry of Hospitalized Patients No drug interventions Not Available Not Available recruiting NCT01073345
Portal Venous Hemodynamic Changes After Hepatectomy No drug interventions Not Available Not Available unknown_status NCT03263598
Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites No drug interventions Not Available Not Available completed NCT01701297
VSL#3 and Spontaneous Bacterial Peritonitis treatment 2 terminated NCT04701697
Phase Ib of Recombinant Human Albumin Injection treatment 1 completed NCT00796861
Trial of Sunitinib for Refractory Malignant Ascites treatment 2 terminated NCT02742428
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer No drug interventions supportive_care Not Available suspended NCT01716611
Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites treatment 4 unknown_status NCT04315571
Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents No drug interventions treatment Not Available active_not_recruiting NCT00358878
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) treatment 3 completed NCT05025878
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients. No drug interventions Not Available Not Available recruiting NCT03327688
Point-of-care Ultrasound in Finland No drug interventions diagnostic Not Available completed NCT06436807
PMCF Study of the CE-marked Drainova® ArgentiC Catheter No drug interventions Not Available Not Available recruiting NCT01331785
Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis treatment Not Available withdrawn NCT00603200
Effect of Large Volume Paracentesis on Fatigue in Cirrhosis No drug interventions Not Available Not Available withdrawn NCT03827200
A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis treatment 2 terminated NCT05309200
A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury treatment 2 completed NCT02891642
Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid No drug interventions Not Available Not Available unknown_status NCT06553742
High Definition Profiling of Ovarian Cancer Ascites No drug interventions Not Available Not Available not_yet_recruiting NCT05278013
Utility of 2- Octyl Cyanoacrylate (2-OCA) No drug interventions health_services_research Not Available enrolling_by_invitation NCT01150916
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites No drug interventions diagnostic Not Available completed NCT00239096
Prevention of Decompensation in Liver Cirrhosis prevention 4 unknown_status NCT02120196
Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis prevention 3 unknown_status NCT02649335
To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites treatment 3 completed NCT01349335
Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites treatment 2 completed NCT00741663
Spironolactone Versus Spironolactone Plus Furosemide (SVSSF) treatment 4 completed NCT00501722
Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites treatment 2 completed NCT01349348
Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites treatment 3 completed NCT01578226
Procalcitonin in Cirrhotic Patients at High Risk for Sepsis No drug interventions Not Available Not Available completed NCT00501566
Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites treatment 2 completed NCT00548366
Sodium Restriction in the Management of Cirrhotic Ascites No drug interventions treatment 4 terminated NCT04279327
Cell Block Immunohistochemistry in Effusion Cytology No drug interventions Not Available Not Available unknown_status NCT01288794
Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis treatment 4 completed NCT05220891
Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study No drug interventions Not Available Not Available unknown_status NCT01359462
Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis treatment 1 completed NCT00327444
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites treatment 2 / 3 completed NCT01769040
Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis basic_science 4 completed NCT03493204
Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial No drug interventions treatment Not Available completed NCT01292304
Tolvaptan for Ascites in Cirrhotic Patients treatment 4 completed NCT02787772
Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? No drug interventions supportive_care Not Available completed NCT00591968
Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community No drug interventions health_services_research Not Available completed NCT01188746
Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites No drug interventions supportive_care Not Available completed NCT01455246
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis treatment 2 / 3 terminated NCT02022150
Body Composition Analysis in Cirrhotic Undergoing Paracentesis No drug interventions Not Available Not Available unknown_status NCT05900050
Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® No drug interventions treatment 2 recruiting NCT05700708
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites No drug interventions Not Available Not Available recruiting NCT04641364
Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects. treatment 1 completed NCT03341221
Diagnosis of Ascites in Infants and Children No drug interventions Not Available Not Available unknown_status NCT05013502
Empagliflozin in Diuretic Refractory Ascites treatment 1 completed NCT01091233
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study No drug interventions Not Available Not Available withdrawn NCT04533854
Investigating Signal Change in Malignant and Non-malignant Pleural Effusions and asCitic Fluid Using fTiR Analysis No drug interventions Not Available Not Available completed NCT02638051
Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT No drug interventions treatment 2 completed NCT04245553
Does Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis? No drug interventions supportive_care Not Available completed NCT00825877
Long-term Follow-up of HALT-C Sustained Virological Responders No drug interventions Not Available Not Available completed NCT00115947
Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites Not Available 2 / 3 completed NCT03210298
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) No drug interventions Not Available Not Available unknown_status NCT05569798
The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial No drug interventions diagnostic Not Available not_yet_recruiting NCT01801228
Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects treatment 2 withdrawn NCT03506893
Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients No drug interventions treatment Not Available recruiting NCT01777971
The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis No drug interventions Not Available Not Available withdrawn NCT01030185
Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance No drug interventions treatment 2 / 3 completed NCT03267615
VICIS - Vienna Cirrhosis Study No drug interventions Not Available Not Available recruiting NCT00359437
Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver treatment 3 terminated NCT00760032
Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients diagnostic 4 withdrawn NCT04675775
The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. No drug interventions treatment Not Available completed NCT04112199
A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites treatment 2 terminated NCT02811406
The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites prevention Not Available unknown_status NCT00005906
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis treatment 2 completed NCT02895919
Bedside Inoculation of Ascitic Fluid in Diagnostic Paracentesis No drug interventions Not Available Not Available withdrawn NCT00490217
Spontaneous Bacterial Peritonitis: Incidence, Risk Factors and Outcome No drug interventions Not Available Not Available completed NCT04640116
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites No drug interventions treatment Not Available unknown_status NCT01059396
Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal prevention 4 completed NCT02608658
Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites No drug interventions supportive_care Not Available completed NCT01236339
Early TIPS for Ascites Study No drug interventions treatment Not Available terminated NCT00570622
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis treatment 4 completed NCT03205748
Evaluation of Different Etiologies of Obscure Ascites No drug interventions Not Available Not Available unknown_status NCT02975726
Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites treatment Not Available completed NCT03973866
Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study) No drug interventions treatment Not Available active_not_recruiting NCT05511766
Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis prevention 2 / 3 recruiting NCT00006166
North American Study for the Treatment of Refractory Ascites (NASTRA) No drug interventions treatment 3 completed NCT03069131
Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites treatment 3 completed NCT00907673
The Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure No drug interventions treatment Not Available completed NCT00511394
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis diagnostic Not Available suspended NCT04550091
Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites No drug interventions Not Available Not Available unknown_status NCT05734729
Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve Outcomes No drug interventions treatment Not Available recruiting NCT02755701
The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites treatment 4 unknown_status NCT04650295
Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial No drug interventions treatment Not Available completed NCT00968695
Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. treatment 4 completed NCT00366795
Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver treatment 3 terminated NCT00108355
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis treatment 4 completed NCT01421550
Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver Cirrhosis No drug interventions treatment 3 unknown_status